AR077739A1 - Tapones lagrimales - Google Patents

Tapones lagrimales

Info

Publication number
AR077739A1
AR077739A1 ARP100101012A ARP100101012A AR077739A1 AR 077739 A1 AR077739 A1 AR 077739A1 AR P100101012 A ARP100101012 A AR P100101012A AR P100101012 A ARP100101012 A AR P100101012A AR 077739 A1 AR077739 A1 AR 077739A1
Authority
AR
Argentina
Prior art keywords
plugs
tear
tear plugs
anchor
elongated
Prior art date
Application number
ARP100101012A
Other languages
English (en)
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of AR077739A1 publication Critical patent/AR077739A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00772—Apparatus for restoration of tear ducts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)

Abstract

Se describen tapones lagrimales adecuados para suministrar agentes terapéuticos; los tapones tienen un cuerpo, una porcion en la cual se carga el agente terapéutico, un bobinado alrededor del cuerpo, y una alargada o de anclaje en un extremo.
ARP100101012A 2009-03-31 2010-03-29 Tapones lagrimales AR077739A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16541709P 2009-03-31 2009-03-31

Publications (1)

Publication Number Publication Date
AR077739A1 true AR077739A1 (es) 2011-09-21

Family

ID=42320849

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100101012A AR077739A1 (es) 2009-03-31 2010-03-29 Tapones lagrimales

Country Status (14)

Country Link
US (1) US20100256578A1 (es)
EP (1) EP2413853A1 (es)
JP (1) JP2012521858A (es)
KR (1) KR20120013346A (es)
CN (1) CN102448412A (es)
AR (1) AR077739A1 (es)
AU (1) AU2010234879A1 (es)
BR (1) BRPI1014062A2 (es)
CA (1) CA2758054A1 (es)
RU (1) RU2011143792A (es)
SG (2) SG10201401086VA (es)
TW (1) TWI495459B (es)
UY (1) UY32538A (es)
WO (1) WO2010117722A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
US9421127B2 (en) * 2009-03-31 2016-08-23 Johnson & Johnson Vision Care, Inc. Punctal plugs
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US9259352B2 (en) * 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US9259351B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US20110301555A1 (en) * 2010-06-03 2011-12-08 Gonzalez-Zugasti Javier P Porous matrix drug core for lacrimal insert device
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
WO2015184173A1 (en) 2014-05-29 2015-12-03 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
CN104398328A (zh) * 2014-09-30 2015-03-11 浦易（上海）生物技术有限公司 一种可完全降解的载药的鼻泪管支架及其植入系统
US11925578B2 (en) 2015-09-02 2024-03-12 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
CN105879126A (zh) * 2016-03-24 2016-08-24 杭州亚慧生物科技有限公司 一种超润滑血清白蛋白泪点塞及其制备方法
CN109937025B (zh) 2016-04-20 2022-07-29 多斯医学公司 生物可吸收眼部药物的递送装置
CN106667656A (zh) * 2016-06-30 2017-05-17 广州聚明生物科技有限公司 生物可降解泪道栓及其制备方法和应用
CN106491270B (zh) * 2016-12-23 2018-08-14 中国医科大学附属第一医院 一种泪点扩张装置
CN110711075A (zh) * 2018-07-11 2020-01-21 吴坚 一种泪小管栓塞
WO2022182740A1 (en) 2021-02-24 2022-09-01 Ocular Therapeutix, Inc. Intracanalicular depot inserter device

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906551A (en) * 1974-02-08 1975-09-23 Klaas Otter Artificial intra-ocular lens system
US3949750A (en) * 1974-10-07 1976-04-13 Freeman Jerre M Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
US4915684A (en) * 1988-06-21 1990-04-10 Mackeen Donald L Method and apparatus for modulating the flow of lacrimal fluid through a punctum and associated canaliculus
US4959048A (en) * 1989-01-17 1990-09-25 Helix Medical, Inc. Lacrimal duct occluder
US5334137A (en) * 1992-02-21 1994-08-02 Eagle Vision, Inc. Lacrimal fluid control device
US5423777A (en) * 1993-10-27 1995-06-13 Tajiri; Akira Punctum plug
US6149684A (en) * 1995-06-07 2000-11-21 Herrick; Robert S. Punctum plug having a thin elongated lip and a distal starting tip and method of using
EP0944371A1 (fr) * 1997-02-04 1999-09-29 Alain Fouere Tampon meatique vissable pour canal lacrymal
US6082362A (en) * 1997-03-27 2000-07-04 Eagle Vision, Inc. Punctum plug
US6041785A (en) * 1997-03-27 2000-03-28 Eaglevision, Inc. Punctum plug
US6822016B2 (en) * 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US6367929B1 (en) * 1998-03-02 2002-04-09 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US5962548A (en) * 1998-03-02 1999-10-05 Johnson & Johnson Vision Products, Inc. Silicone hydrogel polymers
US6196993B1 (en) * 1998-04-20 2001-03-06 Eyelab Group, Llc Ophthalmic insert and method for sustained release of medication to the eye
US6099852A (en) * 1998-09-23 2000-08-08 Johnson & Johnson Vision Products, Inc. Wettable silicone-based lenses
US6629533B1 (en) * 2000-06-30 2003-10-07 Eagle Vision, Inc. Punctum plug with at least one anchoring arm
FR2829019B3 (fr) * 2001-08-31 2003-10-31 Alain Fouere Bouchons lacrymaux et methodes de mise en place de ces dispositifs
US7204253B2 (en) * 2003-05-22 2007-04-17 Clarity Corporation Punctum plug
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
EP3470108A1 (en) * 2004-07-02 2019-04-17 Mati Therapeutics Inc. Treatment medium delivery device for delivery of treatment media to the eye
US20060020253A1 (en) * 2004-07-26 2006-01-26 Prescott Anthony D Implantable device having reservoir with controlled release of medication and method of manufacturing the same
US20060276738A1 (en) * 2005-06-06 2006-12-07 Becker Bruce B Lacrimal drainage bypass device and method
US8088161B2 (en) * 2005-07-28 2012-01-03 Visioncare Ophthalmic Technologies Inc. Compressed haptics
CN103393483B (zh) * 2006-03-31 2016-08-24 玛提治疗有限公司 用于鼻泪系统的药物释放方法、结构及组合物
US9474645B2 (en) * 2006-06-21 2016-10-25 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
SG138567A1 (en) * 2006-06-21 2008-01-28 Johnson & Johnson Vision Care Punctal plugs for the delivery of active agents
US20080045911A1 (en) * 2006-06-21 2008-02-21 Borgia Maureen J Punctal plugs for the delivery of active agents
CA2674076A1 (en) 2006-12-26 2008-07-10 Qlt Plug Delivery, Inc. Drug delivery implants for inhibition of optical defects
UY30883A1 (es) * 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
US20090104243A1 (en) * 2007-09-07 2009-04-23 Qlt Plug Delivery, Inc. - Qpdi Drug cores for sustained release of therapeutic agents
TWI542338B (zh) * 2008-05-07 2016-07-21 壯生和壯生視覺關懷公司 用於活性劑之控制釋放的眼用裝置
CN102341144B (zh) * 2009-01-23 2014-10-29 Qlt股份有限公司 一种或多种药剂的持续释放递送
WO2010107826A2 (en) * 2009-03-16 2010-09-23 Endoshape, Inc. Reliably retained shape memory ophthal-mological implants

Also Published As

Publication number Publication date
JP2012521858A (ja) 2012-09-20
WO2010117722A1 (en) 2010-10-14
CA2758054A1 (en) 2010-10-14
AU2010234879A1 (en) 2011-10-27
SG174972A1 (en) 2011-11-28
BRPI1014062A2 (pt) 2016-04-12
TW201039805A (en) 2010-11-16
RU2011143792A (ru) 2013-05-10
SG10201401086VA (en) 2014-10-30
US20100256578A1 (en) 2010-10-07
EP2413853A1 (en) 2012-02-08
TWI495459B (zh) 2015-08-11
KR20120013346A (ko) 2012-02-14
UY32538A (es) 2010-09-30
CN102448412A (zh) 2012-05-09

Similar Documents

Publication Publication Date Title
AR077739A1 (es) Tapones lagrimales
UY32537A (es) Tapones lagrimales
CR20120345A (es) Derivados de 3-hidroxi-5-arilisotiazol novedosos
CL2016002372A1 (es) Cenicriviroc para el tratamiento de la fibrosis.
CL2011001811A1 (es) Un metodo para tratar un paciente que ha sufrido un infarto agudo al miocardio que comprende el uso de un agente antifibrotico.
CL2015000345A1 (es) Uso de una combinación para el melanoma que comprende la administración de cobimetinib y vemurafenib.
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
CR20150216A (es) Composiciones y métodos para tratar proteinopatías
CO6640295A2 (es) Conjunto de anclaje que incluye un anclaje expansible
CL2012002037A1 (es) Uso de agonista doble del glucagon-glp-1 como agente inotropico en el tratamiento de la cardiopatía o la disfuncion cardiaca
DOP2012000245A (es) Composiciones sólidas
CL2011000916A1 (es) Uso de una combinacion de un inhibidor de proteasoma epoxicetona peptidica o una sal farmaceutica aceptable del mismo, y uno o mas de otros agentes terapeuticos para tratar el cancer.
CL2017001964A1 (es) Encapsulado de agentes activos de alta potencia.
IL254813B (en) Sustained-release injectable formulations containing isoxazoline active agent and methods and uses thereof
CL2013000718A1 (es) Un complejo de inclusion que comprende a) una ciclodextrina, b) fulvestrant y c) un portador; su metodo de preparacion; formulacion y forma de dosificacion que comprende al complejo; preparacion que comprende al complejo o a la formulación; y su uso en el tratamiento del cancer y lupus eritematoso sistemico, entre otras enfermedades.
CL2014001002A1 (es) Perno de anclaje en roca que incluye un cuerpo cilindrico alargado que tiene, un primer extremo distal y un segundo extremo proximal opuesto, una porcion roscada en el segundo extremo, un primer anclaje situado en o al menos parcialmente situado en una primera porcion de extremo del cuerpo, un segundo anclaje, una primera porcion de vastago entre el primer y el segundo anclaje.
AR105205A1 (es) Sustrato adhesivo desechable adaptado para ser dispuesto sobre un dispositivo médico
WO2016149501A3 (en) Modified therapeutic agents and compositions thereof
BRPI0910760A2 (pt) método para remineralizar tecido, agente remineralizador, e, kit
CL2017000050A1 (es) Terapia de combinación para el cáncer
AR084677A1 (es) Tapones lagrimales para la liberacion controlada de agentes terapeuticos
CO6480985A2 (es) Formulaciones para el tratamiento del dolor tisular profundo
MX2015011784A (es) Dispositivo de terapia para periimplantitis.
PE20161158A1 (es) Aparato y metodo de apoyo en tierra
CL2013002905A1 (es) Composición farmacéutica que comprende fimasartan, una sal, solvato o hidrato del mismo y amlodipina, un isómero, sal, solvato o hidrato del mismo; uso en el tratamiento de hipertensión y enfermedades cardiovasculares.

Legal Events

Date Code Title Description
FB Suspension of granting procedure